MARY GIBBONS: Open Payments
NPI 1578061313 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 43 payments from 11 companies in 2025. Trend: 2023 $1,602 · 2024 $1,604 · 2025 $964
Food & beverage: $964
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $207 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $179 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $122 |
| PFIZER INC. | 6 | $114 |
| HEARTFLOW, INC. | 4 | $101 |
| Novartis Pharmaceuticals Corporation | 5 | $87 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Impulse Dynamics (USA) Inc. | 1 | $33 |
| Amgen Inc. | 1 | $30 |
Products named: LifeVest, JARDIANCE, Wegovy, ELIQUIS, FFRct, LEQVIO, Ozempic, CAMZYOS.
Industry payments across PA — which companies pay providers there.
